YC Drug Discovery and Delivery Companies
42 Y Combinator drug discovery and delivery startups with verified founder contacts, batch info, and company data.
42
Companies
40
Active
0
Acquired
1
Public
YC Company Directory
42 companies
Company | Batch | Description | Status | Location | Team | Site | Founders | Reveal |
|---|---|---|---|---|---|---|---|---|
CellType | W26 | The agentic drug company. We simulate human biology. | Active | New York, NY, USA | 2 | David van Dijk, Ivan Vrkic | Reveal | |
Ditto Biosciences | W26 | Evolutionary therapies for autoimmune disease | Active | San Francisco, CA, USA | 3 | Adair Borges, Dennis Sun, Emily Weiss | Reveal | |
Strand AI | W26 | Curated multimodal datasets for biology AI | Active | San Francisco, CA, USA | 2 | Yue Dai, Oded Falik | Reveal | |
Adventris Pharmaceuticals | W23 | Adventris makes cancer vaccines | Active | Baltimore, MD, USA | 7 | Jen Herbach, William Collis, Mark Yarchoan | Reveal | |
Diffuse Bio | W23 | Generative AI for protein design | Active | San Carlos, CA, USA | 10 | Namrata Anand | Reveal | |
Invitris | W23 | Creating new protein-based drugs at scale | Active | Munich, Germany | 6 | Patrick Grossmann, Kilian Vogele | Reveal | |
Lavo Life Sciences | W23 | AI for drug formulation | Inactive | — | 3 | Scott Swarthout, Zach Glick, Derek Metcalf | Reveal | |
Miracle | W23 | Accelerate clinical trials with real-time, actionable insights | Active | San Francisco, CA, USA | 6 | Jin Kim | Reveal | |
Persist AI | W23 | Developing long-lasting drug formulations 50% faster | Active | Woodland, CA, USA | 6 | Karthik Raman, Christopher Shelner | Reveal | |
Rosebud Biosciences | W22 | Growing micro-organs to find new drugs | Active | San Francisco, CA, USA | 3 | Kitch Wilson, Evan Lyall | Reveal | |
WhiteLab Genomics | W22 | Unleashing the potential of DNA and RNA based therapies using AI | Active | Paris, France | 40 | David Delbourgo, Julien Cottineau | Reveal | |
Abalone Bio | W20 | We create activating antibodies to treat diseases others can’t. | Active | Emeryville, CA, USA | 14 | Richard Yu, Gustavo Pesce | Reveal | |
Algen Biotechnologies | W20 | Using CRISPR to find treatments for cancer and inflammation | Active | San Francisco, CA, USA | 13 | Chun-Hao Huang, Christine Du | Reveal | |
General Proximity | W20 | The next generation of induced-proximity medicines. | Active | San Francisco, CA, USA | 15 | Armand Cognetta | Reveal | |
Menten AI | W20 | Menten AI designs peptide and protein therapeutics using quantum… | Active | San Francisco, CA, USA | 2 | Tamas Gorbe, Hans Melo | Reveal | |
PostEra | W20 | Medicinal Chemistry powered by Machine Learning | Active | Boston, MA, USA | 40 | Aaron Morris, Alpha Lee, Matthew Robinson | Reveal | |
Avro Life Science | W18 | Skin patches for generic drug delivery. | Active | Waterloo, ON, Canada | 8 | Shak Lakhani, Keean Sarani | Reveal | |
Macromoltek | W18 | Computational antibody design | Active | Austin, TX, USA | 14 | Monica Berrondo, Susana Kaufmann | Reveal | |
Sixfold Bioscience | W18 | Delivering RNA therapies. | Active | London, UK | 27 | George Foot, Anna Perdrix Rosell | Reveal | |
Numerion Labs | W15 | Artificial intelligence for drug discovery. | Active | San Francisco, CA, USA | 67 | Abraham Heifets, Alex Levy, Izhar Wallach | Reveal | |
b12 Labs | S25 | Chemical Copilot for Pharma and Biotech | Active | San Francisco, CA, USA | 2 | Zlatko Jončev, Andres Bran | Reveal | |
Convexia | S25 | The world's first AI-maximalist pharma company | Active | — | 4 | Ayaan Parikh, Rahul Vijayan | Reveal | |
Ångström AI | S24 | Gen AI molecular simulations that reproduce wetlab results | Active | San Francisco, CA, USA | 5 | Javier Antoran, Jose Miguel Hernandez Lobato, Laurence Midgley | Reveal | |
Biocartesian | S24 | Converting biology into digital molecular maps | Active | San Francisco, CA, USA | 2 | Ian Dardani, Jess Li | Reveal | |
Nanograb | S23 | AI-generated binders for targeted drug delivery | Active | San Francisco, CA, USA | 5 | Debesh Mandal, Christopher Lau, Shanil Panara | Reveal | |
Olio Labs | S23 | Combination therapeutics for the world's toughest diseases | Active | — | 5 | David Tingley, Tom Roseberry | Reveal | |
iollo | S22 | Building Quinn, an AI scientist accelerating pharma/biotech R&D | Active | San Francisco, CA, USA | 4 | Daniel Gomari | Reveal | |
Adaptyv | S21 | We're building fully automated labs for protein engineering | Active | Lausanne, Switzerland | 12 | Julian Englert, Daniel Nakhaee-Zadeh Gutierrez | Reveal | |
CellChorus | S21 | The dynamic single-cell analysis company | Active | Houston, TX, USA | 4 | Dan Meyer, Navin Varadarajan | Reveal | |
Harmonic Discovery | S21 | Multi-targeted therapeutics to treat complex diseases | Active | New York, NY, USA | 8 | Rayees Rahman, J Lee, Marcel Patek | Reveal | |
Matrubials | S21 | Developing milk-inspired therapeutics for infectious diseases | Active | Davis, CA, USA | 4 | Bruce German, Carlito Lebrilla, David Mills | Reveal | |
Mindstate Design Labs | S21 | Clinical-stage AI neuroengineering platform | Active | San Francisco, CA, USA | 7 | Dillan DiNardo, Tom Ray | Reveal | |
Parallel Bio | S21 | Using the immune system to cure disease | Active | Cambridge, MA, USA | 9 | Robert DiFazio, Juliana Hilliard | Reveal | |
Pirouette Pharma | S21 | We make injections as easy as pushing a button! | Active | Boston, MA, USA | 9 | Conor Cullinane, Matthew Kane, Elijah Kapas | Reveal | |
Talus Bio | S21 | Discovering drugs that target the DNA regulome | Active | Seattle, WA, USA | 16 | Alex Federation, Lindsay Pino | Reveal | |
Gilgamesh Pharmaceuticals | S20 | Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company… | Active | New York, NY, USA | 15 | JONATHAN SPORN, Andrew Kruegel, Dalibor Sames | Reveal | |
Nabla Bio | S20 | We use AI to design antibodies for intractable diseases | Active | Boston, MA, USA | 8 | Surge Biswas, Frances Anastassacos | Reveal | |
Pardes Biosciences | S20 | We break viruses | Public | San Francisco, CA, USA | 2 | Uri Lopatin | Reveal | |
Arpeggio Bio | S19 | Arpeggio Bio develops drugs targeting transcription factors using AI… | Active | Boulder, CO, USA | 20 | Joey Azofeifa | Reveal | |
Synkrino Biotherapeutics | S18 | Synkrino's AI, SATIS is a powerful, unbiased discovery system for… | Active | Oakland, CA, USA | 2 | Jason Barbour, David Ott | Reveal | |
Exonic | F25 | Crowdsourcing drug discovery. | Active | San Francisco, CA, USA | 3 | Ben Brimacombe | Reveal | |
Reticular | F24 | Interpretable AI for drug discovery | Active | San Francisco, CA, USA | 2 | John Yang | Reveal |
About YC Drug Discovery and Delivery Companies
Y Combinator has funded 42 drug discovery and delivery companies since its founding in 2005. These startups span from early-stage pre-launch to publicly traded companies, making YC one of the most prolific backers of drug discovery and delivery innovation globally.
40 of these companies are currently active. 1 have gone public. VCBacked tracks verified founder contact information, team sizes, and company status for every YC drug discovery and delivery startup.
Related Industries
Get the full drug discovery and delivery dataset
Verified founder emails, CSV export, and advanced filters for all 42 YC drug discovery and delivery companies.
Sign Up FreeNo credit card required